{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:41:14Z","timestamp":1792478474266,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003356","name":"Gazi \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2020\/39\/I\/ST4\/02904"],"award-info":[{"award-number":["2020\/39\/I\/ST4\/02904"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejmech.2024.116397","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T12:47:51Z","timestamp":1713185271000},"page":"116397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling"],"prefix":"10.1016","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5640-9700","authenticated-orcid":false,"given":"Mohammed","family":"Hawash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Abudayyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarob","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abu Shamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Aghbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"\u00c7apan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Abualhasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"G\u00f3ral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina Maria","family":"Dominiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorooq","family":"Sobuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116397_bib1","series-title":"World Cancer Report: Cancer Research for Cancer Prevention","author":"Cancer","year":"2020"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116397_bib2","first-page":"61","article-title":"Gynecological cancer update. Asian journal of oncology","volume":"2","author":"Sekhon","year":"2016"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116397_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/a-0898-7347","article-title":"Highlights on specific biological targets; cyclin-dependent kinases, epidermal growth factor receptors, ras protein, and cancer stem cells in anticancer drug development","volume":"69","author":"Hawash","year":"2019","journal-title":"Drug Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib4","first-page":"59","article-title":"Antiproliferative activities of some biologically important scaffold. FABAD J","volume":"43","author":"Hawash","year":"2017","journal-title":"Pharm. Sci"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116397_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.ejmech.2024.116397_bib6","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/biom12121843","article-title":"Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy","volume":"12","author":"Hawash","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.116397_bib7","doi-asserted-by":"crossref","first-page":"214316","DOI":"10.1016\/j.ccr.2021.214316","article-title":"Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX\u20131 and COX\u20132 enzymes","volume":"453","author":"Khan","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116397_bib8","first-page":"116633","article-title":"Synthetic methodology-enabled discovery of a tunable indole template for COX-1 inhibition and anti-cancer activity. Bioorganic & Medicinal Chemistry","volume":"57","author":"Faura","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116397_bib9","first-page":"432","article-title":"From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation. European journal of medicinal chemistry","volume":"47","author":"Zhong","year":"2012"},{"key":"10.1016\/j.ejmech.2024.116397_bib10","first-page":"82","article-title":"Design, synthesis and biological evaluation of some novel benzothiazole\/benzoxazole and\/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Bioorganic chemistry","volume":"74","author":"Abdelgawad","year":"2017"},{"issue":"10","key":"10.1016\/j.ejmech.2024.116397_bib11","first-page":"8","article-title":"Lactadherin inhibits secretory phospholipase A2 activity on pre-apoptotic leukemia cells","author":"Nyegaard","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116397_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jcp.10068","article-title":"Many actions of cyclooxygenase-2 in cellular dynamics and in cancer","volume":"190","author":"Cao","year":"2002","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116397_bib13","first-page":"1599","article-title":"Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. The American journal of pathology","volume":"167","author":"Secchiero","year":"2005"},{"key":"10.1016\/j.ejmech.2024.116397_bib14","first-page":"215","article-title":"Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Breast cancer research and treatment","volume":"89","author":"Sivula","year":"2005"},{"key":"10.1016\/j.ejmech.2024.116397_bib15","first-page":"1","article-title":"Celecoxib enhanced the cytotoxic effect of cisplatin in chemo-resistant gastric cancer xenograft mouse models through a cyclooxygenase-2-dependent manner. European Journal of Pharmacology","volume":"776","author":"Xu","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116397_bib16","first-page":"1","article-title":"Angiogenesis. Annu. Rev. Med","volume":"57","author":"Folkman","year":"2006"},{"key":"10.1016\/j.ejmech.2024.116397_bib17","first-page":"122","article-title":"Design, synthesis and molecular docking study of novel quinoxalin-2 (1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity. European Journal of Medicinal Chemistry","volume":"86","author":"Galal","year":"2014"},{"key":"10.1016\/j.ejmech.2024.116397_bib18","series-title":"Seminars in Oncology","article-title":"The role of COX-2 inhibition in breast cancer treatment and prevention","author":"Arun","year":"2004"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116397_bib19","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA: a cancer journal for clinicians"},{"issue":"27","key":"10.1016\/j.ejmech.2024.116397_bib20","first-page":"2229","article-title":"COX-2 and colorectal cancer. Current pharmaceutical design","volume":"9","author":"Ferrandez","year":"2003"},{"issue":"6","key":"10.1016\/j.ejmech.2024.116397_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The role of COX-2 in intestinal inflammation and colorectal cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116397_bib22","first-page":"625","article-title":"Cox-2-selective inhibitors: the new super aspirins. Molecular pharmacology","volume":"55","author":"DeWitt","year":"1999"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116397_bib23","first-page":"5683","article-title":"Cyclooxygenase-2 in cancer: a review. Journal of cellular physiology","volume":"234","author":"Hashemi Goradel","year":"2019"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116397_bib24","first-page":"3461","article-title":"Synthesis of 1, 2, 4-triazolopyridazines, isoxazolofuropyridazines, and tetrazolopyridazines as antimicrobial agents. Journal of Heterocyclic Chemistry","volume":"57","author":"Abu-Hashem","year":"2020"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116397_bib25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3987\/COM-15-13290","article-title":"Synthesis and anti-hypertensive \u03b1-blocking activity evaluation of thiazole derivatives bearing pyrazole moiety","volume":"91","author":"Gomha","year":"2015","journal-title":"Heterocycles: an international journal for reviews and communications in heterocyclic chemistry"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116397_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3906\/kim-1506-13","article-title":"Synthesis and evaluation of some novel thiazoles and 1, 3-thiazines as potent agents against the rabies virus","volume":"40","author":"Abdalla","year":"2016","journal-title":"Turk. J. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2024.116397_bib27","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.3390\/molecules25194565","article-title":"Clean grinding technique: a facile synthesis and in silico antiviral activity of hydrazones, pyrazoles, and pyrazines bearing thiazole moiety against SARS-CoV-2 main protease (Mpro)","volume":"25","author":"Abu-Melha","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116397_bib28","first-page":"1505","article-title":"Synthesis of pyrazolyl-Pyrazoles and pyrazolyl-[1, 2, 4]-triazolo [3, 4-d][1, 5] Benzothiazepines as p53 Activators using hydrazonoyl chlorides. Journal of heterocyclic chemistry","volume":"53","author":"Gomha","year":"2016"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116397_bib29","first-page":"2487","article-title":"Efficient synthesis and antimicrobial evaluation of new azolopyrimidines-bearing pyrazole moiety. Journal of heterocyclic chemistry","volume":"56","author":"Abdelhamid","year":"2019"},{"key":"10.1016\/j.ejmech.2024.116397_bib30","first-page":"1685","article-title":"Novel anti-HIV-1 NNRTIs based on a pyrazolo [4, 3-d] isoxazole. Information Med. Chem","volume":"5","author":"Gomha","year":"2014","journal-title":"Commun. Now."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116397_bib31","first-page":"1471","article-title":"Cyclooxygenase-2 (COX-2) as a target of anticancer agents: a review of novel synthesized scaffolds having anticancer and COX-2 inhibitory potentialities. Pharmaceuticals","volume":"15","author":"Mohsin","year":"2022"},{"issue":"10","key":"10.1016\/j.ejmech.2024.116397_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1349-7006.2006.00275.x","article-title":"Suppression of azoxymethane-induced colon cancer development in rats by a cyclooxygenase-1 selective inhibitor, mofezolac","volume":"97","author":"Niho","year":"2006","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib33","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1038\/s41598-020-63377-x","article-title":"Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents","volume":"10","author":"Kumari","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116397_bib34","first-page":"1","article-title":"Evaluation of cytotoxic, COX inhibitory, and antimicrobial activities of novel isoxazole-carboxamide derivatives. Letters in Drug Design & Discovery","volume":"19","author":"Hawash","year":"2022"},{"issue":"12","key":"10.1016\/j.ejmech.2024.116397_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-022-03408-8","article-title":"Molecular docking studies and biological evaluation of isoxazole-carboxamide derivatives as COX inhibitors and antimicrobial agents","volume":"12","author":"Hawash","year":"2022","journal-title":"3 Biotech"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib36","first-page":"11","article-title":"Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors. BMC Chemistry","volume":"17","author":"Hawash","year":"2023"},{"issue":"32","key":"10.1016\/j.ejmech.2024.116397_bib37","doi-asserted-by":"crossref","first-page":"29512","DOI":"10.1021\/acsomega.3c03256","article-title":"New thiazole carboxamide derivatives as COX inhibitors: design, synthesis, anticancer screening, in silico molecular docking, and ADME profile studies","volume":"8","author":"Hawash","year":"2023","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1515\/hc-2020-0105","article-title":"Synthesis and biological evaluation of benzodioxole derivatives as potential anticancer and antioxidant agents","volume":"26","author":"Hawash","year":"2020","journal-title":"Heterocycl. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-022-00839-5","article-title":"Synthesis of novel isoxazole\u2013carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability","volume":"16","author":"Hawash","year":"2022","journal-title":"BMC chemistry"},{"key":"10.1016\/j.ejmech.2024.116397_bib40","first-page":"132","article-title":"Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents. Bioorganic Chemistry","volume":"57","author":"Abdelazeem","year":"2014"},{"issue":"21","key":"10.1016\/j.ejmech.2024.116397_bib41","first-page":"6831","article-title":"Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3\u2032-hydroxy-4\u2032-methoxyphenyl)-3-(3 \u2033, 4 \u2033, 5 \u2033-trimethoxybenzoyl)-6-methoxyindole (OXi 8006). Bioorganic & medicinal chemistry","volume":"21","author":"MacDonough","year":"2013"},{"key":"10.1016\/j.ejmech.2024.116397_bib42","first-page":"24","article-title":"Design, synthesis and anticancer activity of trifluoromethylphenylamino substituted spiroindoles. Journal of Fluorine Chemistry","volume":"216","author":"Budovsk\u00e1","year":"2018"},{"key":"10.1016\/j.ejmech.2024.116397_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2023.12.003","article-title":"In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models","author":"Lee","year":"2023","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.ejmech.2024.116397_bib44","first-page":"836480","article-title":"3D cell cultures: Evolution of an ancient tool for new applications. Frontiers in Physiology","volume":"13","author":"Cacciamali","year":"2022"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116397_bib45","first-page":"283","article-title":"Tumor-derived spheroids: relevance to cancer stem cells and clinical applications. Cancer science","volume":"108","author":"Ishiguro","year":"2017"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116397_bib46","first-page":"2048","article-title":"Three-dimensional (3D) liver cell models-a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials. Drug Delivery and Translational Research","volume":"12","author":"Tutty","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116397_bib47","doi-asserted-by":"crossref","first-page":"113885","DOI":"10.1016\/j.biopha.2022.113885","article-title":"Gundelia tournefortii inhibits hepatocellular carcinoma progression by lowering gene expression of the cell cycle and hepatocyte proliferation in immunodeficient mice","volume":"156","author":"Amer","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116397_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/biomimetics7040247","article-title":"Anticancer activity of thiophene carboxamide derivatives as CA-4 biomimetics: synthesis, biological potency, 3D spheroid model, and molecular dynamics simulation","volume":"7","author":"Hawash","year":"2022","journal-title":"Biomimetics"},{"issue":"21","key":"10.1016\/j.ejmech.2024.116397_bib49","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1039\/D3NA00269A","article-title":"Green synthesis of fluorescent carbon nanodots from sage leaves for selective anticancer activity on 2D liver cancer cells and 3D multicellular tumor spheroids","volume":"5","author":"Sawalha","year":"2023","journal-title":"Nanoscale Adv."},{"issue":"47","key":"10.1016\/j.ejmech.2024.116397_bib50","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1038\/sj.onc.1206945","article-title":"Alterations in the apoptotic machinery and their potential role in anticancer drug resistance","volume":"22","author":"Kaufmann","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116397_bib51","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/molecules23051038","article-title":"Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data?","volume":"23","author":"Ram\u00edrez","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116397_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11030-009-9140-1","article-title":"Docking and quantitative structure\u2013activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase","volume":"13","author":"Caballero","year":"2009","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/med.2610110104","article-title":"The concept of molecular structure in structure\u2013activity relationship studies and drug design","volume":"11","author":"Testa","year":"1991","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116397_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/open.201600015","article-title":"Melting point distribution analysis of globally approved and discontinued drugs: a research for improving the chance of success of drug design and discovery","volume":"5","author":"Mao","year":"2016","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.ejmech.2024.116397_bib55","article-title":"Oxford university press","author":"Patrick","year":"2013","journal-title":"An introduction to medicinal chemistry"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib56","first-page":"855","article-title":"Synthesis, chemo-informatics, and anticancer evaluation of fluorophenyl-isoxazole derivatives. Open Chemistry","volume":"19","author":"Hawash","year":"2021"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib57","first-page":"133","article-title":"Design, synthesis, and biological evaluation of phenyl-isoxazole-carboxamide derivatives as anticancer agents. Heterocyclic Communications","volume":"27","author":"Hawash","year":"2021"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-021-00793-8","article-title":"Synthesis of novel indole-isoxazole hybrids and evaluation of their cytotoxic activities on hepatocellular carcinoma cell lines","volume":"15","author":"Hawash","year":"2021","journal-title":"BMC chemistry"},{"key":"10.1016\/j.ejmech.2024.116397_bib59","doi-asserted-by":"crossref","first-page":"6633297","DOI":"10.1155\/2021\/6633297","article-title":"Synthesis and biological evaluation of novel isoxazole-amide analogues as anticancer and antioxidant agents","volume":"2021","author":"Eid","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116397_bib60","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/biom13101486","article-title":"Characterization and investigation of novel benzodioxol derivatives as antidiabetic agents: an in vitro and in vivo study in an animal model","volume":"13","author":"Hawash","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116397_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"xds. Acta Crystallographica Section D: Biological Crystallography"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116397_bib62","first-page":"133","volume":"66","author":"Kabsch","year":"2010","journal-title":"Integration, scaling, space-group assignment and post-refinement. Acta Crystallographica Section D: Biological Crystallography"},{"key":"10.1016\/j.ejmech.2024.116397_bib63","series-title":"Crystal Structure of 4-Benzyl-2h-Benzo [b][1, 4] Thiazin-3 (4H)-One. Acta Crystallographica Section E: Crystallographic Communications","first-page":"71","author":"Sebbar","year":"2015"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116397_bib64","first-page":"339","article-title":"OLEX2: a complete structure solution, refinement and analysis program. Journal of applied crystallography","volume":"42","author":"Dolomanov","year":"2009"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib65","first-page":"193","article-title":"DiSCaMB: a software library for aspherical atom model X-ray scattering factor calculations with CPUs and GPUs. Journal of applied crystallography","volume":"51","author":"Chodkiewicz","year":"2018"},{"issue":"16","key":"10.1016\/j.ejmech.2024.116397_bib66","first-page":"3752","article-title":"Multipolar atom types from theory and statistical clustering (MATTS) Data Bank: restructurization and extension of UBDB. Journal of chemical information and modeling","volume":"62","author":"Jha","year":"2022"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116397_bib67","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1039\/D0SC05526C","article-title":"Accurate crystal structures and chemical properties from NoSpherA2","volume":"12","author":"Kleemiss","year":"2021","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1107\/S2053273319015304","article-title":"Refinement of organic crystal structures with multipolar electron scattering factors","volume":"76","author":"Gruza","year":"2020","journal-title":"Acta Crystallogr. A: Foundations and Advances"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116397_bib69","first-page":"1131","article-title":"COX-2 inhibitors\u2013a lesson in unexpected problems. New England Journal of Medicine","volume":"352","author":"Drazen","year":"2005"},{"key":"10.1016\/j.ejmech.2024.116397_bib70","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.3c05695","article-title":"Biological evaluation of xanthene and thioxanthene derivatives as antioxidant, anticancer, and COX inhibitors","author":"Abualhasan","year":"2023","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116397_bib71","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/adfm.200801271","article-title":"Doxorubicin-conjugated immuno-nanoparticles for intracellular anticancer drug delivery","volume":"19","author":"Shi","year":"2009","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejmech.2024.116397_bib72","doi-asserted-by":"crossref","first-page":"105077","DOI":"10.1016\/j.tiv.2021.105077","article-title":"Assessment of perfluorooctanoic acid toxicity in pancreatic cells","volume":"72","author":"Abudayyak","year":"2021","journal-title":"Toxicol. Vitro"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib73","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gene.2015.10.061","article-title":"Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro","volume":"576","author":"Fahrio\u011flu","year":"2016","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.ejmech.2024.116397_bib74","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The protein data bank","volume":"58","author":"Berman","year":"2002","journal-title":"Acta Crystallographica Section D: Biological Crystallography"},{"key":"10.1016\/j.ejmech.2024.116397_bib75","first-page":"661","article-title":"Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6). European journal of medicinal chemistry","volume":"138","author":"Cingolani","year":"2017"},{"issue":"13","key":"10.1016\/j.ejmech.2024.116397_bib76","first-page":"1605","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis. Journal of computational chemistry","volume":"25","author":"Pettersen","year":"2004"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116397_bib77","first-page":"1000","article-title":"Comparison of automatic three-dimensional model builders using 639 X-ray structures. Journal of chemical information and computer sciences","volume":"34","author":"Sadowski","year":"1994"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116397_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116397_bib79","first-page":"455","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry","volume":"31","author":"Trott","year":"2010"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:33:03Z","timestamp":1717219983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424002770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":79,"alternative-id":["S0223523424002770"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116397","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116397"}}